The central focus of Dr. Lindsley's laboratory is on myeloid malignancies [such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)] and bone marrow failure syndromes. His lab uses genomic technologies to study samples from patients with these diseases as a way to define pathways of disease initiation and progression, and to identify mutations that predict outcomes after various treatments. He uses mouse and cell line models to dissect the mechanisms by which these gene mutations cause disease.

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Jazz Pharmaceuticals
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube


Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect


Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811